Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)
Here's the second half of the presentation by Dr. Gerard Silvestri, expert pulmonologist and critical care specialist at the Medical University of South Carolina in Charleston, on pulmonary complications from lung cancer treatment. In this part, he briefly covers the side effects of some systemic targeted therapies used as a treatment for lung cancer, then covers the important topic of radiation pneumonitis in some detail.
Here is the podcast in video and audio versions, along with the transcript and figures.
[powerpress]
Dr. Silvestri Pulm Complics LC Treatment Targeted Rx and RT Pneumonitis Audio Podcast
Dr. Silvestri Pulm Complics LC Treatment Targeted Rx and RT Pneumonitis Transcript
Dr. Silvestri Pulm Complics LC Treatment Targeted Rx and RT Pneumonitis Figs
I hope this program is helpful. We'll be moving on to our next webinar, with Dr. Vivek Mehta covering refinements in increasingly targeted radiation therapy approaches for lung cancer, in the next few weeks.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…